Exhibit 99.1
KEWAUNEE SCIENTIFIC REPORTS RESULTS FOR FIRST QUARTER AND QUARTERLY DIVIDEND
STATESVILLE, N.C., Aug. 23 /PRNewswire-FirstCall/ -- Kewaunee Scientific
Corporation (Nasdaq: KEQU) today reported results for its first quarter ended
July 31, 2006.
Sales for the quarter were $19,294,000, a decrease of 5% from sales of
$20,308,000 in the same period last year. Domestic sales of laboratory and
technical furniture products declined 8%, while sales of the Company's Asian
subsidiaries increased 22%. The order backlog at July 31, 2006 was $36.5
million, up slightly from $36.4 million at April 30, 2006.
Net earnings for the quarter were $133,000, or $0.05 per diluted share. Net
earnings for the comparable period of the prior year, which benefited from an
after-tax gain of $540,000 related to the sale of the Company's property in
Texas, were $763,000, or $0.31 per diluted share. Excluding the gain on the sale
of the property, net earnings in the prior year period were $223,000, or $0.09
per diluted share.
"The domestic market for laboratory and technical furniture products
remains very competitive and price sensitive," said William A. Shumaker,
President and Chief Executive Officer. "Pricing pressures, the continuing
escalating costs of raw materials and energy, and higher borrowing costs
continue to impact earnings. At the same time, however, our Asian subsidiaries
continue to experience strong sales and earnings growth and have become a
significant source of our revenue and earnings.
"Looking forward," Mr. Shumaker continued, "we remain committed to
improving our profitability, both in the domestic and international markets. We
are confident our plans for improving manufacturing efficiencies and reducing
costs will allow us to successfully compete in the worldwide marketplace. We are
continuing to aggressively expand our sales representation and capabilities in
India and China to take advantage of the rapidly-growing Asian laboratory
research market."
The Company's balance sheet remained strong at the end of the quarter.
Working capital was $11.0 million, including cash on hand of $2.1 million.
Stockholders' equity was $25.5 million, or $10.22 per share. Total bank debt and
capital lease obligations at July 31, 2006 were $9.4 million, resulting in a
debt to equity ratio of .37-to-1.
The Company also announced today that its Board of Directors approved a
cash dividend of seven cents per outstanding share to stockholders of record at
the close of business on September 6, 2006, payable on September 20, 2006.
Kewaunee Scientific Corporation is a recognized leader in the design,
manufacture, and installation of scientific and technical furniture. The
Company's corporate headquarters and manufacturing facilities are located in
Statesville, North Carolina. The Company also has subsidiaries in Singapore and
Bangalore, India that serve the Asian markets. Kewaunee Scientific's website is
located at http://www.kewaunee.com.
Certain statements in this release constitute "forward-looking" statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and prices.
Consolidated Statements of Operations [unaudited]
(in thousands, except per share data)
Three Months Ended
--------------------------
July 31 July 31
2006 2005
----------- -----------
Net sales $ 19,294 $ 20,308
Cost of products sold 16,166 16,922
Gross profit 3,128 3,386
Other operating income -- 884*
Operating expenses 2,637 2,920
Operating earnings 491 1,350
Other income (expense) 18 (5)
Interest expense (187) (87)
Earnings before income taxes 322 1,258
Income tax expense 78 457
Earnings before minority interests 244 801
Minority interests in subsidiaries 111 38
Net earnings $ 133 $ 763*
Net earnings per share
Basic $ 0.05 $ 0.31
Diluted $ 0.05 $ 0.31
Weighted average number of common shares
outstanding (in thousands)
Basic 2,492 2,492
Diluted 2,493 2,492
* Includes a non-recurring pretax gain of $884,000 and an after-tax gain of
$540,000, or $.22 per diluted share, on the sale of property.
Condensed Consolidated Balance Sheets
(in thousands)
July 31 April 30
2006 2006
----------- -----------
[unaudited]
Assets
Cash and cash equivalents $ 2,087 $ 929
Restricted cash 400 399
Receivables, less allowances 19,114 23,199
Inventories 6,156 5,860
Prepaid expenses and other current assets 1,298 1,011
Total current assets 29,055 31,398
Net property, plant and equipment 11,129 11,163
Other assets 8,012 7,911
Total Assets $ 48,196 $ 50,472
Liabilities and Stockholders' Equity
Short-term borrowings $ 8,531 $ 8,216
Current obligations under capital leases 297 260
Accounts payable 6,526 9,074
Other current liabilities 2,690 2,823
Total current liabilities 18,044 20,373
Other non-current liabilities 4,682 4,553
Total stockholders' equity 25,470 25,546
Total Liabilities and Stockholders' Equity $ 48,196 $ 50,472
Contact: D. Michael Parker
704/871-3290
SOURCE Kewaunee Scientific Corporation
-0- 08/23/2006
/CONTACT: D. Michael Parker of Kewaunee Scientific Corporation,
+1-704-871-3290/
/Web site: http://www.kewaunee.com /
(KEQU)